The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

Many DexCom, Inc. ( NASDAQ:DXCM ) insiders ditched their stock over the past year, which may be of interest to ...

The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...

Android 15 was launched a few months ago, and discussion is already turning to Android 16, which is currently in the testing ...

The On-Body Drug Delivery Devices market is witnessing significant growth, driven by the increasing demand for ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

Dexcom is focused on its applications in the ... As acknowledged by the FDA, however, Stelo could also find a market among a growing number of healthy people. Some may want to use CGM to spot ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms can overlap between diabetes and dementia.

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...